3 results
Approved WMOCompleted
To evaluate the plasma pharmacokinetic properties and safety of the research medication in healthy volunteers and in Patients with Systemic Mastocytosis and Allergic Asthma.
Approved WMOCompleted
Objective of the study is to demonstrate that CRT parameter optimisation using SonR technology can improve the responder rate, when using LV remodeling as a reference, compared to Standard of Care.
Approved WMOCompleted
Primary objective: To evaluate the efficacy of IVIg treatment (4 courses of treatment, 3 weeks apart) compared to placebo on pain alleviation. Secondary objectives: 1. Pain intensity, pain qualities, and other SFN related complaints, daily and…